China Infrastructure Construction (CHNC) Stock Price, News & Analysis

Company Overview

China Infrastructure Construction Corp. provides educational systems that focuses on medical cannabis in the United States and Latin America, and worldwide through online education. The company offers services in the therapeutic areas of clinical trials; and relating to sleep disorders, including resulting infertility, through its fertility and sleep center in Houston, Texas. It also offers education, consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. The company was founded in 2003 and is headquartered in Houston, Texas.

Key Stats

• Today's Range: $0.0005 to $0.0005
• 50-Day Range: N/A
• 52-Week Range: $0.0004 to $0.0005
• Volume: N/A
• Average Volume: 3.07 million shs
• Market Capitalization: N/A
• P/E Ratio: 0.00
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CHNC Stock Analysis - Frequently Asked Questions

How have CHNC shares performed this year?

China Infrastructure Construction's stock was trading at $0.0005 on January 1st, 2024. Since then, CHNC shares have increased by 0.0% and is now trading at $0.0005.
View the best growth stocks for 2024 here.

How do I buy shares of China Infrastructure Construction?

Shares of CHNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of China Infrastructure Construction own?

Based on aggregate information from My MarketBeat watchlists, some other companies that China Infrastructure Construction investors own include Fernhill (FERN), Puget Technologies (PUGE), Amazonas Florestal (AZFL), Ayr Strategies (AYRSF), Anavex Life Sciences (AVXL), AVVAA World Health Care Products (AVVH) and APT Systems (APTY).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers—Specialty & Generic
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:CHNC
• CUSIP: N/A
• CIK: 1411057
• Web: www.chnc-hdh.com
• Phone: (832) 606-7500
• Fax: N/A
• Employees: 389
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 0.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A